Filing Details

Accession Number:
0000950170-24-028807
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-08 17:38:11
Reporting Period:
2024-03-06
Accepted Time:
2024-03-08 17:38:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1863127 Tyra Biosciences Inc. TYRA Pharmaceutical Preparations (2834) 831476348
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1880946 Daniel Bensen C/O Tyra Biosciences, Inc.
2656 State Street
Carlsbad CA 92008
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-06 1,733 $20.09 431,951 No 4 S Direct
Common Stock Disposition 2024-03-07 68 $20.00 431,883 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.
  2. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.39. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.